Literature DB >> 17178790

Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.

Javier Santander1, Soo-Young Wanda, Cheryl A Nickerson, Roy Curtiss.   

Abstract

Regulation of the synthesis of Vi polysaccharide, a major virulence determinant in Salmonella enterica serotype Typhi, is under the control of two regulatory systems, ompR-envZ and rscB-rscC, which respond to changes in osmolarity. Some serotype Typhi strains exhibit overexpression of Vi polysaccharide, which masks clinical detection of lipopolysaccharide O antigen. This variation in Vi polysaccharide and O antigen display (VW variation) has been observed since the initial studies of serotype Typhi. In this study, we report that rpoS plays a role in this increased expression in Vi polysaccharide. We constructed a variety of isogenic serotype Typhi mutants that differed in their expression levels of RpoS and examined the role of the rpoS product in synthesis of Vi polysaccharide under different osmolarity conditions. Vi polysaccharide synthesis was also examined in serotype Typhi mutants in which the native promoter of the rpoS was replaced by an araCP(BAD) cassette, so that the expression of rpoS was arabinose dependent. The RpoS(-) strains showed increased syntheses of Vi polysaccharide, which at low and medium osmolarities masked O antigen detection. In contrast, RpoS(+) strains showed lower syntheses of Vi polysaccharide, and an increased detection of O antigen was observed. During exponential growth, when rpoS is unstable or present at low levels, serotype Typhi RpoS(+) strains overexpress the Vi polysaccharide at levels comparable to those for RpoS(-) strains. Our results show that RpoS is another regulator of Vi polysaccharide synthesis and contributes to VW variation in serotype Typhi, which has implications for the development of recombinant attenuated Salmonella vaccines in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178790      PMCID: PMC1828562          DOI: 10.1128/IAI.00888-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  71 in total

1.  Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.

Authors:  M M Levine; C Ferreccio; P Abrego; O S Martin; E Ortiz; S Cryz
Journal:  Vaccine       Date:  1999-10-01       Impact factor: 3.641

2.  Genetic dynamics of Salmonella typhi--diversity in clonality.

Authors:  T Pang
Journal:  Trends Microbiol       Date:  1998-09       Impact factor: 17.079

3.  Differential early interactions between Salmonella enterica serovar Typhi and two other pathogenic Salmonella serovars with intestinal epithelial cells.

Authors:  D L Weinstein; B L O'Neill; D M Hone; E S Metcalf
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

5.  A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results.

Authors:  M H Wahdan; C Sérié; Y Cerisier; S Sallam; R Germanier
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

6.  Construction and evaluation of a delta cya delta crp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens.

Authors:  K Roland; R Curtiss; D Sizemore
Journal:  Avian Dis       Date:  1999 Jul-Sep       Impact factor: 1.577

7.  Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice.

Authors:  C Coynault; F Norel
Journal:  Microb Pathog       Date:  1999-06       Impact factor: 3.738

8.  The RcsB-RcsC regulatory system of Salmonella typhi differentially modulates the expression of invasion proteins, flagellin and Vi antigen in response to osmolarity.

Authors:  N Arricau; D Hermant; H Waxin; C Ecobichon; P S Duffey; M Y Popoff
Journal:  Mol Microbiol       Date:  1998-08       Impact factor: 3.501

9.  A coagglutination method for presumptive identification of Salmonella typhi.

Authors:  M Lesmana; R C Rockhill; W R Sanborn
Journal:  Southeast Asian J Trop Med Public Health       Date:  1980-06       Impact factor: 0.267

10.  The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a.

Authors:  V Robbe-Saule; F Norel
Journal:  FEMS Microbiol Lett       Date:  1999-01-01       Impact factor: 2.742

View more
  27 in total

1.  Fur-regulated iron uptake system of Edwardsiella ictaluri and its influence on pathogenesis and immunogenicity in the catfish host.

Authors:  Javier Santander; Greg Golden; Soo-Young Wanda; Roy Curtiss
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

Review 2.  Typhoid fever: "you can't hit what you can't see".

Authors:  Tamding Wangdi; Sebastian E Winter; Andreas J Bäumler
Journal:  Gut Microbes       Date:  2012-03-01

Review 3.  Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity.

Authors:  James E Galen; Amanda D Buskirk; Sharon M Tennant; Marcela F Pasetti
Journal:  EcoSal Plus       Date:  2016-11

4.  The Salmonella enterica serotype Typhi Vi capsular antigen is expressed after the bacterium enters the ileal mucosa.

Authors:  Quynh T Tran; Gabriel Gomez; Sangeeta Khare; Sara D Lawhon; Manuela Raffatellu; Andreas J Bäumler; Dharani Ajithdoss; Soma Dhavala; L Garry Adams
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

5.  Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice.

Authors:  Huoying Shi; Shifeng Wang; Roy Curtiss
Journal:  Clin Vaccine Immunol       Date:  2013-04-24

6.  Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.

Authors:  Huoying Shi; Javier Santander; Karen E Brenneman; Soo-Young Wanda; Shifeng Wang; Patti Senechal; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

7.  Mechanisms of intrinsic resistance to antimicrobial peptides of Edwardsiella ictaluri and its influence on fish gut inflammation and virulence.

Authors:  Javier Santander; Taylor Martin; Amanda Loh; Camilo Pohlenz; Delbert M Gatlin; Roy Curtiss
Journal:  Microbiology (Reading)       Date:  2013-05-15       Impact factor: 2.777

8.  A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.

Authors:  Yuhua Li; Shifeng Wang; Wei Xin; Giorgio Scarpellini; Zhaoxing Shi; Bronwyn Gunn; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

9.  The capsule-encoding viaB locus reduces intestinal inflammation by a Salmonella pathogenicity island 1-independent mechanism.

Authors:  Takeshi Haneda; Sebastian E Winter; Brian P Butler; R Paul Wilson; Cagla Tükel; Maria G Winter; Ivan Godinez; Renée M Tsolis; Andreas J Bäumler
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

10.  Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes.

Authors:  Wendy S Bollen; Bronwyn M Gunn; Hua Mo; Margarita K Lay; Roy Curtiss
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.